Avay Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-07-2024
- Paid Up Capital ₹ 0.12 M
as on 16-07-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -33.12%
(FY 2023)
- Profit -1626.49%
(FY 2023)
- Ebitda -964.68%
(FY 2023)
- Net Worth 20.90%
(FY 2023)
- Total Assets -9.03%
(FY 2023)
About Avay Biosciences
The Corporate was formerly known as Tvasta Bio-Science Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Amin, Ratnesh Jain, Vettiyoor Adithya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U22219KA2017PTC103861
- Company No.
103861
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Avay Biosciences Private Limited offer?
Avay Biosciences Private Limited offers a wide range of products and services, including CAD CAM Design & Consultancy, CAD Service, 3D Printer & Services, 3D Printer, Material Testing Labs & Services, Laboratory Testing Services, Computer Hardware & Network Support, Printer Repair & Maintenance Services, Electrical & Electronic Goods Rental, Electronic Equipment Rental.
Who are the key members and board of directors at Avay Biosciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Amin  | Director | 08-May-2021 | Current |
| Ratnesh Jain | Director | 08-May-2021 | Current |
| Vettiyoor Adithya | Director | 14-Jun-2017 | Current |
| Parivarthan Basireddy | Director | 05-Nov-2019 | Current |
| Kornipalli Sabareesh | Additional Director | 15-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Avay Biosciences.
Avay Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.12% decrease. The company also saw a substantial fall in profitability, with a 1626.49% decrease in profit. The company's net worth Soared by an impressive increase of 20.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avay Biosciences?
In 2023, Avay Biosciences had a promoter holding of 75.68% and a public holding of 24.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tvasta Manufacturing Solutions Private LimitedActive 8 years 4 monthsVettiyoor Adithya and Parivarthan Basireddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avay Biosciences?
Unlock and access historical data on people associated with Avay Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avay Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avay Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
